A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus
Clinical trial NCT07347080 · RECRUITING
Trial details
- NCT number
- NCT07347080
- Sponsor
- The First Affiliated Hospital of Henan University of Science and Technology
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-20
- Primary completion
- 2026-08-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.